Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 8.

Article

Jones, RP, Psarelli, E-E, Jackson, R et al. (37 more authors) (2019) Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. JAMA Surgery. ISSN 2168-6254

Patil, S, Babu, N, Subbannayya, T et al. (11 more authors) (2019) Secretome analysis of oral keratinocytes chronically exposed to shisha. Cancer Biomarkers, 25 (1). pp. 29-41. ISSN 1574-0153

Patil, S, Patel, K, Advani, J et al. (9 more authors) (2019) Multiomic analysis of oral keratinocytes chronically exposed to shisha. Journal of Oral Pathology and Medicine, 48 (4). pp. 284-289. ISSN 0904-2512

Patil, S, Subbannayya, T, Mohan, SV et al. (11 more authors) (2019) Proteomic Changes in Oral Keratinocytes Chronically Exposed to Shisha (Water Pipe). OMICS A Journal of Integrative Biology, 23 (2). pp. 86-97. ISSN 1536-2310

Scully, D, Sfyri, P, Verpoorten, S et al. (8 more authors) (2019) Platelet releasate promotes skeletal myogenesis by increasing muscle stem cell commitment to differentiation and accelerates muscle regeneration following acute injury. Acta Physiologica, 225 (3). e13207. ISSN 1748-1708

Sfyri, PP, Yuldasheva, NY orcid.org/0000-0001-6213-6358, Tzimou, A et al. (9 more authors) (2018) Attenuation of oxidative stress-induced lesions in skeletal muscle in a mouse model of obesity-independent hyperlipidaemia and atherosclerosis through the inhibition of Nox2 activity. Free Radical Biology and Medicine, 129. pp. 504-519. ISSN 0891-5849

Neoptolemos, JP, Palmer, DH, Ghaneh, P et al. (31 more authors) (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet, 389 (10073). pp. 1011-1024. ISSN 0140-6736

King, HO, Brend, T, Payne, HL et al. (8 more authors) (2017) RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells. Stem Cell Reports, 8 (1). pp. 125-139.

This list was generated on Sun Nov 24 12:00:49 2019 GMT.